Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bausch Health Companies Inc
(NY:
BHC
)
7.730
+0.550 (+7.66%)
Streaming Delayed Price
Updated: 9:41 AM EDT, Sep 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
993,124
Open
7.480
Bid (Size)
7.730 (5)
Ask (Size)
7.750 (1)
Prev. Close
7.180
Today's Range
7.390 - 7.790
52wk Range
3.960 - 11.46
Shares Outstanding
358,808,755
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Contact Lens Supplier Bausch + Lomb Eyes Sale Amid Separation Challenges As Parent Bausch Health Faces Debt Issues
September 16, 2024
Bausch + Lomb is exploring a sale as its parent company, Bausch Health, faces significant debt and creditors' opposition to a spin-off.
Via
Benzinga
Topics
Supply Chain
Exposures
Supply Chain
Bausch Reportedly Explores A Sale; Could Alcon, J&J Or AbbVie Buy It?
September 16, 2024
Bausch + Lomb is reportedly considering a sale. But its potential acquirers could come up against antitrust concerns.
Via
Investor's Business Daily
Performance
YTD
-0.64%
-0.64%
1 Month
+34.43%
+34.43%
3 Month
+19.47%
+19.47%
6 Month
-18.97%
-18.97%
1 Year
-7.65%
-7.65%
More News
Read More
Bank Of Canada Cuts Rates Again As Inflation, Labor Market Cool: Canadian Stocks Rebound, Loonie Strengthens
September 04, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Bausch Health Announces 2024 Gastrointestinal Health Scholars Program Winners
August 13, 2024
Via
ACCESSWIRE
Bausch Health Solvency Remains A Concerns, Analyst Downgrades Stock
August 02, 2024
Via
Benzinga
Bausch Health Announces Second Quarter 2024 Results
July 30, 2024
Via
ACCESSWIRE
Apple, Amazon, Microsoft, Meta Lead The Charge As Investors Bank On Tech Cheer For Rally's Reacceleration: Week Ahead In Earnings
July 29, 2024
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Bausch Health Responds to Market Rumors
July 24, 2024
Via
ACCESSWIRE
US Stocks Tumble On Economic, Geopolitical Concerns; Small Caps, Chipmakers Sink; Meta Rallies: What's Driving Markets Thursday?
August 01, 2024
Via
Benzinga
BHC Stock Plunges as Bausch Health Appears on the Brink of Bankruptcy
July 24, 2024
Via
InvestorPlace
Topics
Bankruptcy
Exposures
Financial
Legal
Bausch Health Welcomes Two New Members to the Executive Leadership Team
July 19, 2024
Via
ACCESSWIRE
Bausch Health Announces 2024 Annual Meeting of Shareholder Results
May 15, 2024
Via
ACCESSWIRE
Wall Street Looks To Ride On Earnings Cheer As Meta Q2 Impresses Investors: Analyst Says Economic Data, Stock Performances Suggest Republican Win In November
August 01, 2024
Via
Benzinga
Why Bausch health Shares Are Falling Today
July 24, 2024
Via
Benzinga
Topics
Bankruptcy
Exposures
Financial
Legal
Stocks Plummet After Tech Earnings, Manufacturing Data
July 24, 2024
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 24, 2024
Via
Benzinga
Bausch Health to Announce Second Quarter 2024 Results on August 1, 2024
July 11, 2024
Via
ACCESSWIRE
Bausch Health Brings Patent Infringement Lawsuit Against Norwich Pharmaceuticals
June 20, 2024
Via
ACCESSWIRE
Bausch Health Reports Promising R&D Trial Updates on Amiselimod and Scientific Data Presented at International Healthcare Conferences
June 14, 2024
Via
ACCESSWIRE
Bausch Health, Canada Inc. Announces Additional Public Drug Plan Listings for PrUCERIS(R) (Budesonide) Aerosol Foam To Treat Mild to Moderate Distal Ulcerative Colitis in Adults
May 23, 2024
Via
ACCESSWIRE
Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024
May 17, 2024
Via
ACCESSWIRE
Bausch Health Announces Updates Related to Norwich XIFAXAN Matters
May 14, 2024
Via
ACCESSWIRE
Salix Pharmaceuticals announces Bellamy Young as Spokesperson for Xifaxan(R) (rifaximin)
May 09, 2024
Via
ACCESSWIRE
Why Bausch Health Companies Stock Dived by More Than 7% Today
May 02, 2024
Via
The Motley Fool
BHC Stock Earnings: Bausch Health Companies Misses EPS, Misses Revenue for Q1 2024
May 02, 2024
Via
InvestorPlace
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.